| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2025 ( Subtotal = $0 ) |
| 2025 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201 | BALTIMORE CITY | USA | Lung Diseases Research | 000 | 4 | 10/17/2024 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $452,531 ) |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201 | BALTIMORE CITY | USA | Lung Diseases Research | 000 | 4 | 8/26/2024 | NON-COMPETING CONTINUATION | $452,531 |
|
| Issue Date FY: 2023 ( Subtotal = $465,628 ) |
| 2023 | 2023 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201 | BALTIMORE CITY | USA | Lung Diseases Research | 000 | 3 | 8/15/2023 | NON-COMPETING CONTINUATION | $465,628 |
|
| Issue Date FY: 2022 ( Subtotal = $465,627 ) |
| 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201 | BALTIMORE CITY | USA | Lung Diseases Research | 000 | 2 | 8/8/2022 | NON-COMPETING CONTINUATION | $465,627 |
|
| Issue Date FY: 2021 ( Subtotal = $465,628 ) |
| 2021 | 2021 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201 | BALTIMORE CITY | USA | Lung Diseases Research | 000 | 1 | 9/1/2021 | NEW | $465,628 |
|
|